Global Health Limited (NSE: MEDANTA)
India
· Delayed Price · Currency is INR | Market Cap | 298.34B |
| Revenue (ttm) | 33.57B |
| Net Income (ttm) | 4.82B |
| Shares Out | 268.55M |
| EPS (ttm) | 17.96 |
| PE Ratio | 61.86 |
| Forward PE | 51.96 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 198,722 |
| Open | 1,140.00 |
| Previous Close | 1,143.10 |
| Day's Range | 1,107.10 - 1,157.95 |
| 52-Week Range | 675.00 - 1,513.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 8, 2024 |
About Global Health
Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peri... [Read more]
Financial Performance
In 2023, Global Health's revenue was 32.75 billion, an increase of 20.86% compared to the previous year's 27.10 billion. Earnings were 4.78 billion, an increase of 46.65%.
Financial StatementsNews
Global Health (Medanta) shares surge over 5% in morning trade
Global Health Limited, operating under the brand name Medanta, is witnessing a significant uptick in its stock price during early trading hours today. Key highlights: Current Trading: Stock Price: ₹1,...